Abstracts

Abstract submission is now closed.
Late-breaking abstracts will be accepted June 3 to 28, providing they meet the criteria described here:



Abstract submission guidelines


  • Abstract are welcome from national and international applicants from all disciplines across the continuum of care, including healthcare providers, researchers, system leaders, and people with lived experience.
  • Authors may submit multiple abstracts as first author or co-author
  • Abstracts may be submitted in English or French and presentations at Congress may be given in either language
  • All abstracts will be peer-reviewed.
  • Each abstract should be a maximum of 250 words (excluding title and authors) and should consist of four separate paragraphs when appropriate:

    • Background : briefly describe the problem or issue being addressed
    • Methods: describe how the study was performed
    • Results: provide results if available, or clearly indicate what results will be available at time of presentation
      • Note: If this is a work in progress and no data are expected to be available for presentation, then the abstract should be submitted as an ‘ongoing clinical trial’. Only one table or figure may be included if required.
      • Only one table or figure may be included if required.
    • Conclusions: describe what the authors conclude from these results

  • Applicants must select one of the following categories at submission where their abstract fits best

    • Acute stroke management
    • Prevention of stroke (primary and secondary)
    • Stroke rehabilitation, recovery, and community care
    • Stroke systems of care.
    • Engagement of people with lived experience with stroke
    • Ongoing clinical trials (Display poster only, not eligible for oral abstracts)

  • Applicants should clearly indicate the preferred format for presentation:

    • Oral presentation - oral presentation eight minutes long plus 2 minutes for questions. Generally, includes completed projects or projects where sufficient data will be available to share with the audience

    • Brag and Steal Presentation - These are three minute presentations (3 slides) + 2 minutes for questions to demonstrate a high-level of innovation, resources, or collaboration in addressing an identified issue or opportunity. They may demonstrate a practical application, resource, or tool that can be shared with Canadian Stroke Congress delegates and others for use in various settings, regions, or provinces by stroke professionals, researchers, or system managers.

    • Display (paper) Poster
      • Note: Top-rated posters may be selected as a digital poster, accompanied by a brief communication (brief oral presentation of poster, using 3 slides in 3 minutes plus 2 min for questions);

  • Learning objectives (at least one and up to three) must be submitted with abstract.
  • Research presented in abstracts must conform to CIHR guidelines for experimental procedures. All investigations involving humans and animals must have been conducted in conformity with these principles.
  • Note: if preferred format is not available, participants may be offered an opportunity to present within a different format.
  • Authors will be asked for confirmation that all presented works are original works or works that have been properly cited, and/or have obtained appropriate permissions to include.

  • Note: The highest-rated abstracts may be eligible for the Co-Chair awards for innovation and for impact. Additional highly rated abstracts may be selected for the 'Top Breakthroughs' plenary session.

  • Note on submission of ongoing clinical trials

    • Ongoing clinical trials may be presented as display (paper) posters only. Clinical trial information boards provide an excellent opportunity for organizers and supporters to:
      • Inform Congress delegates about planned or ongoing registered clinical trials in Canada.
      • Educate the Canadian stroke community about the status and objectives of registered clinical trials in Canada.
      • Identify and recruit potential new centres.
      • Registered trials should be in the advanced planning, recruitment or follow-up phase.
      • Trials that have been completed and published will not be accepted.
      • On-going clinical trials will not be peer reviewed or published in the International Journal of Stroke and will only be accepted as a display poster.
      • Ongoing clinical trials should be randomized clinical trials or prospective observational cohort studies.

Information for presenters following acceptance of an abstract:

  • All presenters must register for the Congress and will be required to pay the appropriate registration fee. Abstract presenters do not receive complimentary registration
  • Abstract notifications will be sent out prior to the end of the early-bird registration period

  • All accepted presenters (oral and poster) will be required to complete a Conflict-of-Interest declaration form
  • Authors must declare any financial interest in a product discussed in the presentation. In general, generic names should always be used rather than specific trade names

  • Display posters will be available for viewing to all delegates throughout the Congress
  • Poster presenters will be asked to be available at their poster to answer questions at set times during Congress